Lotta Alla Sepsi Ospedaliera - Fighting Hospital Sepsis
NCT01804764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1123
Last updated 2023-05-09
Summary
Sepsis is widespread (1.8 million cases annually worldwide) and accounts for a very high mortality: 20-25% of all severe sepsis, 40-70% of all septic shock. The Surviving Sepsis Campaign (SSC) recommends a first 6 hours "resuscitative bundle" to improve patient's outcome. Despite this, the bundle is poorly performed, because of a superficial knowledge of the guidelines and several difficulties in their clinical implementation. In recognition of this, a "sepsis six" bundle is designed to facilitate early intervention with just three diagnostic and three therapeutic steps to be delivered by staff within 1 h.
The aim of our study is to evaluate if an Educational and Organizational Intervention (EOI) could improve septic patient's outcome in no Critical Care Units. The second endpoint is to evaluate if the compliance to the "sepsis six" bundle could improve after this sort of intervention.
Conditions
- Severe Sepsis
Sponsors & Collaborators
-
University of Milano Bicocca
lead OTHER
Principal Investigators
-
Sergio Vesconi, MD · Niguarda Ca' Granda Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
NCT01724463 ·Status: UNKNOWN
-
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126 ·Status: RECRUITING
-
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767 ·Status: UNKNOWN
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Assessment for Implementation Methods in Sepsis
NCT05491941 ·Status: RECRUITING ·Phase: NA
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
NCT06915974 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Accuracy in Sepsis
NCT03956043 ·Status: COMPLETED
-
Medical Education for Sepsis Source Control and Antibiotics
NCT01187134 ·Status: COMPLETED ·Phase: NA
-
Sepsis Institutional Registry in Hospital Italiano de Buenos Aires
NCT01403935 ·Status: COMPLETED
-
Severe Sepsis/Septic Shock on Admission to the General Surgical ICU
NCT01363635 ·Status: RECRUITING
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA
-
Short-course Antimicrobial Therapy in Sepsis
NCT02899143 ·Status: UNKNOWN ·Phase: PHASE2
-
Volemic Resuscitation in Sepsis and Septic Shock
NCT02565251 ·Status: UNKNOWN ·Phase: NA
-
Observational Study on Intubation in Septic Shock
NCT02780466 ·Status: COMPLETED
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mortality of Sepsis in Swedish Intensive Care Units 2008-2016
NCT03489447 ·Status: COMPLETED
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
NCT03217721 ·Status: COMPLETED
-
Fluid Overload Quantification in Septic Shock
NCT04114162 ·Status: COMPLETED
-
Sepsis in the ICU-II
NCT04695119 ·Status: ACTIVE_NOT_RECRUITING
-
International Multicentre Prevalence Study on Sepsis
NCT01943747 ·Status: COMPLETED
-
Blood Gases Versus Lactate Clearance as an Indicator of Initial Resuscitation in Septic Patients: Comparative Study
NCT05049941 ·Status: UNKNOWN
-
Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial
NCT04742764 ·Status: SUSPENDED ·Phase: PHASE3
-
COrporeal Compression at the ONset of Severe Sepsis and Septic Shock
NCT02656654 ·Status: COMPLETED ·Phase: NA